Tommy Rampling

University College London - Comprehensive Biomedical Research Centre

SCHOLARLY PAPERS

2

DOWNLOADS

203

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Demographics and Outcomes of COVID-19 Medicines Delivery Units Across 4 UK Centres During the Initial B1.1.529 Omicron Epidemic: A Service Evaluation.

Number of pages: 16 Posted: 16 Jun 2022
London School of Hygiene & Tropical Medicine, Government of the United Kingdom - University College London Hospital, Guys and St Thomas’ Hospitals NHS Foundation Trust, Dept Infection, Immunity & Cardiovascular Disease, University of Sheffield, Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, Government of the United Kingdom - University College London Hospital, University Hospital Lewisham, Dept of Infectious Diseases & Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, King's College London - Centre for Rheumatic Disease, Guys and St Thomas’ Hospitals NHS Foundation Trust, Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, University College London - Comprehensive Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust - Department of Infectious Diseases, Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, University College London - Department of Infection and London School of Hygiene & Tropical Medicine - Department of Clinical Research
Downloads 159 (357,989)
Citation 3

Abstract:

Loading...

COVID-19, molnupiravir, sotrovimab

2.

COVAC1 Phase 2a Expanded Safety and Immunogenicity Study of a Self-Amplifying RNA Vaccine Against SARS-CoV-2

Number of pages: 33 Posted: 27 Sep 2022
University College London - MRC Clinical Trials Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, University College London - MRC Clinical Trials Unit, St George’s University London - St George’s Vaccine Institute, Government of the United Kingdom - Department of HIV/GUM, Government of the United Kingdom - Department of HIV/GUM, NIHR Imperial Clinical Research Facility - NIHR Imperial Biomedical Research Centre, St George’s University London - St George’s Vaccine Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Imperial College London - Section of Virology, St George’s University London - St George’s Vaccine Institute, University of Surrey - Surrey Clinical Research Centre, Imperial College London - Department of Infectious Disease, NIHR UCLH Clinical Research Facility, Imperial College London - Department of Infectious Disease, Chelsea and Westminster Hospital NHS FT, Imperial College London - Department of Infectious Disease, NIHR Imperial Clinical Research Facility - NIHR Imperial Biomedical Research Centre, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton - NIHR Southampton Biomedical Research Centre, University College London - Comprehensive Biomedical Research Centre, University of Surrey - Surrey Clinical Research Centre, Imperial College London - Department of Infectious Disease, University of Surrey - Surrey Clinical Research Centre, University College London - Comprehensive Biomedical Research Centre, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Imperial College London - Department of Infectious Disease
Downloads 44 (779,944)

Abstract:

Loading...

SARS-CoV-2, vaccination, self-amplifying RNA, saRNA, immune response